Immuneering

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immuneering and other ETFs, options, and stocks.

About IMRX

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis.

CEO

Benjamin J. Zeskind

CEOBenjamin J. Zeskind

Employees

Employees66

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2008

Founded2008

Employees

Employees66

IMRX Key Statistics

Market cap

109.04M

Market cap109.04M

Price-Earnings ratio

-1.53

Price-Earnings ratio-1.53

Dividend yield

—

Dividend yield—

Average volume

4.91M

Average volume4.91M

High today

$3.24

High today$3.24

Low today

$2.79

Low today$2.79

Open price

$2.94

Open price$2.94

Volume

2.30M

Volume2.30M

52 Week high

$3.83

52 Week high$3.83

52 Week low

$1.00

52 Week low$1.00

Analyst ratings

83%

of 6 ratings

Buy

83.3%

Hold

16.7%

Sell

People also own

Based on the portfolios of people who own IMRX. This list is generated using Robinhood data, and it’s not a recommendation.